EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Progress interrogating TRPMPZQ as the target of praziquantel

Jonathan S Marchant iD

PLOS Neglected Tropical Diseases · 2024

DOI: 10.1371/journal.pntd.0011929 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Jonathan S Marchant. Beteiligte Einrichtung: Department of Cell Biology, Neurobiology & Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America. Hauptthemen laut MEDLINE: Anthelmintics, Transient Receptor Potential Channels. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Marcus Family.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The drug praziquantel (PZQ) has served as the long-standing drug therapy for treatment of infections caused by parasitic flatworms. These encompass diseases caused by parasitic blood, lung, and liver flukes, as well as various tapeworm infections. Despite a history of clinical usage spanning over 4 decades, the parasite target of PZQ has long resisted identification. However, a flatworm transient receptor potential ion channel from the melastatin subfamily (TRPM PZQ ) was recently identified as a target for PZQ action. Here, recent experimental progress interrogating TRPM PZQ is evaluated, encompassing biochemical, pharmacological, genetic, and comparative phylogenetic data that highlight the properties of this ion channel. Various lines of evidence that support TRPM PZQ being the therapeutic target of PZQ are presented, together with additional priorities for further research into the mechanism of action of this important clinical drug.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnthelminticsTransient Receptor Potential ChannelsPraziquantelPhylogeny

Substanzen

PraziquantelAnthelminticsTransient Receptor Potential Channels

Autor:innen und Institutionen

  • Department of Cell Biology, Neurobiology & Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.

ORCID-Profile: Jonathan S Marchant

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • Marcus Family

Zitieren

APA

Marchant, J. S. (2024). Progress interrogating TRPMPZQ as the target of praziquantel. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0011929

Vancouver

Marchant JS. Progress interrogating TRPMPZQ as the target of praziquantel. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0011929

BibTeX
@article{Marchant2024,
  author = {Marchant, Jonathan S},
  title = {Progress interrogating TRPMPZQ as the target of praziquantel},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2024},
  doi = {10.1371/journal.pntd.0011929}
}
Kostenlos starten →